Publications by authors named "Keyvan Tadjalli-Mehr"

Claim this Profile
T
TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial.
Aung Naing, Meredith McKean, Anthony Tolcher, Anja Victor, Ping Hu, Keyvan Tadjalli-Mehr

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma.
Jean Hoffman-Censits, Petros Grivas, Thomas Powles, Jessica Hawley, Karin Tyroller

Future Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial.
Martin Reck, Fabrice Barlesi, James Chih-Hsin Yang, Virginie Westeel, Enriqueta Felip

J Thorac Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.
Fatma Doener, Henoch S Hong, Ingo Meyer, Keyvan Tadjalli-Mehr, Angelika Daehling

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
Martin Alberer, Ulrike Gnad-Vogt, Henoch Sangjoon Hong, Keyvan Tadjalli Mehr, Linus Backert

Lancet· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence.
Markus K Diener, Keyvan Tadjalli-Mehr, Moritz N Wente, Meinhard Kieser, Markus W Büchler

Langenbecks Arch Surg· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of serum creatinine measurement error on dose adjustment in renal failure.
Verena Schneider, Volkmar Henschel, Keyvan Tadjalli-Mehr, Ulrich Mansmann, Walter E Haefeli

Clin Pharmacol Ther· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial with fruits and vegetables in prevention of cancer.
Keyvan Tadjalli-Mehr, Nikolaus Becker, Mati Rahu, Aivars Stengrevics, Juozas Kurtinaitis

Acta Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis